Diclofenamidum [Inn-Latin]
Brand names,
Diclofenamidum [Inn-Latin]
Analogs
Diclofenamidum [Inn-Latin]
Brand Names Mixture
Diclofenamidum [Inn-Latin]
Chemical_Formula
C6H6Cl2N2O4S2
Diclofenamidum [Inn-Latin]
RX_link
http://www.rxlist.com/cgi/generic/dichlorphen.htm
Diclofenamidum [Inn-Latin]
fda sheet
Diclofenamidum [Inn-Latin]
msds (material safety sheet)
Diclofenamidum [Inn-Latin]
Synthesis Reference
No information avaliable
Diclofenamidum [Inn-Latin]
Molecular Weight
305.16 g/mol
Diclofenamidum [Inn-Latin]
Melting Point
228.7 oC
Diclofenamidum [Inn-Latin]
H2O Solubility
No information avaliable
Diclofenamidum [Inn-Latin]
State
Solid
Diclofenamidum [Inn-Latin]
LogP
0.37
Diclofenamidum [Inn-Latin]
Dosage Forms
No information avaliable
Diclofenamidum [Inn-Latin]
Indication
For adjunctive treatment of: chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure
Diclofenamidum [Inn-Latin]
Pharmacology
Dichlorphenamide is an oral carbonic anhydrase inhibitor indicated for adjunctive treatment of: chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure. Carbonic anhydrase inhibitors reduce intraocular pressure by partially suppressing the secretion of aqueous humor (inflow).
Diclofenamidum [Inn-Latin]
Absorption
No information avaliable
Diclofenamidum [Inn-Latin]
side effects and Toxicity
No information avaliable
Diclofenamidum [Inn-Latin]
Patient Information
No information avaliable
Diclofenamidum [Inn-Latin]
Organisms Affected
Humans and other mammals